175 related articles for article (PubMed ID: 17645590)
1. Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study.
van Bommel EF; Siemes C; van der Veer SJ; Han SH; Huiskes AW; Hendriksz TR
J Intern Med; 2007 Aug; 262(2):224-34. PubMed ID: 17645590
[TBL] [Abstract][Full Text] [Related]
2. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
[TBL] [Abstract][Full Text] [Related]
3. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis.
van Bommel EF; Hendriksz TR; Huiskes AW; Zeegers AG
Ann Intern Med; 2006 Jan; 144(2):101-6. PubMed ID: 16418409
[TBL] [Abstract][Full Text] [Related]
4. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Pelkmans LG; Aarnoudse AJ; Hendriksz TR; van Bommel EF
Nephrol Dial Transplant; 2012 Jul; 27(7):2819-25. PubMed ID: 22273666
[TBL] [Abstract][Full Text] [Related]
5. Summaries for patients. Tamoxifen for the treatment of retroperitoneal fibrosis.
Ann Intern Med; 2006 Jan; 144(2):I51. PubMed ID: 16418405
[No Abstract] [Full Text] [Related]
6. [67Ga scintigraphy in retroperitoneal fibrosis (RPF): indications, application and clinical relevance--report of five patients].
Hillebrand M; Gerstenberg E; Kuntz RM; L'age M; Grosse G
Nuklearmedizin; 1996 Feb; 35(1):25-30. PubMed ID: 8746169
[TBL] [Abstract][Full Text] [Related]
7. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
[TBL] [Abstract][Full Text] [Related]
10. Gallium-67 scintigraphy to predict response to therapy in active lupus nephritis.
Lin WY; Lan JL; Wang SJ
J Nucl Med; 1998 Dec; 39(12):2137-41. PubMed ID: 9867157
[TBL] [Abstract][Full Text] [Related]
11. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
[TBL] [Abstract][Full Text] [Related]
14. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
[TBL] [Abstract][Full Text] [Related]
15. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
16. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
[TBL] [Abstract][Full Text] [Related]
17. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
18. Early detection of lymphoma recurrence with gallium-67 scintigraphy.
Front D; Bar-Shalom R; Epelbaum R; Haim N; Ben-Arush MW; Ben-Shahar M; Gorenberg M; Kleinhaus U; Parmett S; Kolodny GM
J Nucl Med; 1993 Dec; 34(12):2101-4. PubMed ID: 8254395
[TBL] [Abstract][Full Text] [Related]
19. The value of quantitative gallium-67 single-photon emission tomography in the clinical management of malignant external otitis.
Stokkel MP; Takes RP; van Eck-Smit BL; Baatenburg de Jong RJ
Eur J Nucl Med; 1997 Nov; 24(11):1429-32. PubMed ID: 9371879
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
